To include your compound in the COVID-19 Resource Center, submit it here.

Hydros-TA: Phase II data

In the double-blind, international Phase II COR1.0 trial in 98 patients with osteoarthritis of the knee, Carbylan said a single intra-articular injection of

Read the full 237 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE